ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 312 filers reported holding ROYALTY PHARMA PLC in Q3 2023. The put-call ratio across all filers is 0.16 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,410,250 | +43.5% | 162,500 | +62.5% | 0.01% | +42.9% |
| Q2 2023 | $3,074,000 | +288.9% | 100,000 | +400.0% | 0.01% | +600.0% |
| Q4 2022 | $790,400 | -1.7% | 20,000 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $804,000 | -88.8% | 20,000 | -88.9% | 0.00% | -83.3% |
| Q4 2021 | $7,173,000 | -13.8% | 180,000 | -21.8% | 0.01% | 0.0% |
| Q3 2021 | $8,319,000 | +304.2% | 230,200 | +358.6% | 0.01% | +200.0% |
| Q2 2021 | $2,058,000 | -6.7% | 50,200 | -0.7% | 0.00% | 0.0% |
| Q1 2021 | $2,205,000 | +5.0% | 50,543 | +16.8% | 0.00% | 0.0% |
| Q2 2020 | $2,101,000 | – | 43,276 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SIGULER GUFF ADVISERS, LLC | 6,761,970 | $294,957,000 | 88.74% |
| Vantage Consulting Group Inc | 8,705,551 | $379,735,000 | 76.23% |
| Memorial Sloan Kettering Cancer Center | 2,680,644 | $116,930,000 | 72.07% |
| HARVARD MANAGEMENT CO INC | 10,714,284 | $467,357,000 | 26.11% |
| ROBERT WOOD JOHNSON FOUNDATION | 970,151 | $4,231,798,000 | 21.59% |
| Brown University | 381,759 | $16,652,000 | 11.44% |
| Overbrook Management Corp | 771,155 | $33,638,000 | 7.48% |
| SpiderRock Advisors, LLC | 778,800 | $34,236,000 | 4.79% |
| Renaissance Capital LLC | 452,948 | $19,758,000 | 2.93% |
| Lagoda Investment Management, L.P. | 104,835 | $4,573,000 | 2.28% |